Novartis Doan's Hearing To Review FTC Ruling Set For Feb. 8
This article was originally published in The Tan Sheet
Executive Summary
Oral arguments on Novartis' petition for review of the Federal Trade Commission's corrective advertising order for Doan's pills are scheduled to be heard in D.C. federal appeals court Feb. 8.
You may also be interested in...
CHPA/Nevada AG Meth Retail Education Poster Campaign Under Way
Unusually large retail purchases of OTC cold, allergy, sinus and asthma medicines may signify the items are being used to produce methamphetamine in an illegal lab, recently distributed posters warn retail store clerks.
CHPA/Nevada AG Meth Retail Education Poster Campaign Under Way
Unusually large retail purchases of OTC cold, allergy, sinus and asthma medicines may signify the items are being used to produce methamphetamine in an illegal lab, recently distributed posters warn retail store clerks.
CHPA/Nevada AG Meth Retail Education Poster Campaign Under Way
Unusually large retail purchases of OTC cold, allergy, sinus and asthma medicines may signify the items are being used to produce methamphetamine in an illegal lab, recently distributed posters warn retail store clerks.